GlobeNewswire 2/27/2017 RECORDATI SIGNS AN EXCLUSIVE LICENSE AGREEMENT WITH THE MEYER HOSPITAL IN FLORENCE

GlobeNewswire 2/9/2017 RECORDATI: PRELIMINARY 2016 RESULTS CONFIRM CONTINUED GROWTH OF REVENUES AND PROFITABILITY. NEW THRE...

GlobeNewswire 2/1/2017 RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY AND SPECIALIZED PRESS IN MILAN

GlobeNewswire 1/27/2017 RECORDATI ANNOUNCES MARKETING APPROVAL FOR CYSTADROPS®

GlobeNewswire 8/2/2016 RECORDATI AND RICHTER SIGNED A LICENSE AGREEMENT FOR MARKETING CARIPRAZINE IN WESTERN EUROPE

GlobeNewswire 7/28/2016 RECORDATI: EXCELLENT RESULTS IN THE FIRST HALF 2016. CONTINUED GROWTH IN SALES +9.1%, OPERATING INCO...

GlobeNewswire 7/14/2016 RECORDATI ACQUIRES THE SWISS PHARMACEUTICAL COMPANY PRO FARMA

GlobeNewswire 5/31/2016 RECORDATI ACQUIRES THE ITALIAN PHARMACEUTICAL COMPANY ITALCHIMICI

GlobeNewswire 5/5/2016 RECORDATI: EXCELLENT RESULTS IN THE FIRST QUARTER 2016. SALES +9.6%, OPERATING INCOME +22.7%, NET IN...

GlobeNewswire 4/13/2016 RECORDATI: SHAREHOLDERS APPROVE 2015 ACCOUNTS. DIVIDEND € 0.60 PER SHARE (+20.0% vs 2014)

GlobeNewswire 3/8/2016 RECORDATI: BOARD APPROVES THE 2015 ACCOUNTS. SALES € 1,047.7 MILLION (+6.1%), OPERATING INCOME € 27...

GlobeNewswire 2/29/2016 RARE DISEASE DAY: 29TH FEBRUARY 2016

GlobeNewswire 2/11/2016 RECORDATI : PRELIMINARY 2015 RESULTS: REVENUE GROWTH AND FURTHER MARGIN IMPROVEMENT. SALES +6.1%, OP...

GlobeNewswire 10/9/2014 RECORDATI : initiates a share buy-back program

GlobeNewswire 9/16/2014 RECORDATI : OBTAINS LICENSE TO NEW TREATMENT FOR PREMATURE EJACULATION FROM PLETHORA

GlobeNewswire 7/29/2014 RECORDATI REPORTS EXCELLENT RESULTS IN THE FIRST HALF 2014

GlobeNewswire 7/3/2014 RECORDATI : CARBAGLU® RECEIVES ORPHAN DRUG DESIGNATION IN THE U.S. FOR ORGANIC ACIDEMIAS

GlobeNewswire 5/26/2014 RECORDATI FINALIZES THE SECOND TRANCHE OF ITS ACQUISITION OF OPALIA PHARMA IN TUNISIA.

GlobeNewswire 4/17/2014 RECORDATI : SHAREHOLDERS APPROVE THE 2013 ACCOUNTS. DIVIDEND € 0.33 PER SHARE.

GlobeNewswire 3/6/2014 RECORDATI: BOARD APPROVES THE 2013 ACCOUNTS.

GlobeNewswire 2/26/2014 The European Organisation for Rare Diseases awards Orphan Europe

GlobeNewswire 2/11/2014 RECORDATI : PRELIMINARY 2013 RESULTS SHOW SIGNIFICANT GROWTH. SALES +13.7%, EBIT +17.0%, NET INCOME ...